Published in Oncogene on May 24, 2010
Amino acids and mTORC1: from lysosomes to disease. Trends Mol Med (2012) 2.38
Nutrient signaling to mTOR and cell growth. Trends Biochem Sci (2013) 1.68
Proton-assisted amino acid transporter PAT1 complexes with Rag GTPases and activates TORC1 on late endosomal and lysosomal membranes. PLoS One (2012) 1.30
Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders. Oxid Med Cell Longev (2010) 1.21
Gene networks driving bovine mammary protein synthesis during the lactation cycle. Bioinform Biol Insights (2011) 1.21
Rab12 regulates mTORC1 activity and autophagy through controlling the degradation of amino-acid transporter PAT4. EMBO Rep (2013) 1.19
mTor signaling in skeletal muscle during sepsis and inflammation: where does it all go wrong? Physiology (Bethesda) (2011) 1.16
Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin. Prog Neurobiol (2012) 1.13
The SLC36 family of proton-coupled amino acid transporters and their potential role in drug transport. Br J Pharmacol (2011) 1.13
The emerging role of mTORC1 signaling in placental nutrient-sensing. Placenta (2012) 1.12
Skeletal muscle amino acid transporter expression is increased in young and older adults following resistance exercise. J Appl Physiol (1985) (2011) 1.11
Role of amino acid transporters in amino acid sensing. Am J Clin Nutr (2013) 1.11
Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer. Radiother Oncol (2013) 0.99
Intracellular amino acid sensing and mTORC1-regulated growth: new ways to block an old target? Curr Opin Investig Drugs (2010) 0.96
Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the Spot. Cell Metab (2016) 0.93
Aging differentially affects human skeletal muscle amino acid transporter expression when essential amino acids are ingested after exercise. Clin Nutr (2012) 0.91
SLC36A4 (hPAT4) is a high affinity amino acid transporter when expressed in Xenopus laevis oocytes. J Biol Chem (2010) 0.91
LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation. Nat Commun (2015) 0.89
Regulation of membrane trafficking by signalling on endosomal and lysosomal membranes. J Physiol (2013) 0.87
Soy-dairy protein blend and whey protein ingestion after resistance exercise increases amino acid transport and transporter expression in human skeletal muscle. J Appl Physiol (1985) (2014) 0.86
Abundance of amino acid transporters involved in mTORC1 activation in skeletal muscle of neonatal pigs is developmentally regulated. Amino Acids (2012) 0.86
Current models of mammalian target of rapamycin complex 1 (mTORC1) activation by growth factors and amino acids. Int J Mol Sci (2014) 0.85
Regulation of protein synthesis by amino acids in muscle of neonates. Front Biosci (Landmark Ed) (2011) 0.85
Essential amino acid sensing, signaling, and transport in the regulation of human muscle protein metabolism. Curr Opin Clin Nutr Metab Care (2011) 0.83
Leucyl-tRNA synthetase: double duty in amino acid sensing. Cell Res (2012) 0.83
Energy metabolism regulates clathrin adaptors at the trans-Golgi network and endosomes. Mol Biol Cell (2013) 0.81
PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer. Oncogene (2015) 0.81
Sepsis-induced changes in amino acid transporters and leucine signaling via mTOR in skeletal muscle. Amino Acids (2014) 0.81
Advantages of tandem LC-MS for the rapid assessment of tissue-specific metabolic complexity using a pentafluorophenylpropyl stationary phase. J Proteome Res (2011) 0.80
Amino acid transporters in the regulation of human skeletal muscle protein metabolism. Curr Opin Clin Nutr Metab Care (2013) 0.79
The SLC36 transporter Pathetic is required for extreme dendrite growth in Drosophila sensory neurons. Genes Dev (2015) 0.79
Multifaceted role of insulin-like growth factors and mammalian target of rapamycin in skeletal muscle. Endocrinol Metab Clin North Am (2012) 0.78
Recent Advances in Understanding Amino Acid Sensing Mechanisms that Regulate mTORC1. Int J Mol Sci (2016) 0.78
Chitosan oligosaccharide affects antioxidant defense capacity and placental amino acids transport of sows. BMC Vet Res (2016) 0.77
The current progress and future prospects of personalized radiogenomic cancer study. Biomedicine (Taipei) (2015) 0.77
Functions of the SLC36 transporter Pathetic in growth control. Fly (Austin) (2015) 0.76
Rags to riches: Amino acid sensing by the Rag GTPases in health and disease. Small GTPases (2016) 0.75
PET Tracers Beyond FDG in Prostate Cancer. Semin Nucl Med (2016) 0.75
Amino acid transporters implicated in endocytosis of Buchnera during symbiont transmission in the pea aphid. Evodevo (2016) 0.75
The amino acid transporter SLC36A4 regulates the amino acid pool in retinal pigmented epithelial cells and mediates the mechanistic target of rapamycin, complex 1 signaling. Aging Cell (2017) 0.75
FLCN Maintains the Leucine Level in Lysosome to Stimulate mTORC1. PLoS One (2016) 0.75
The Architecture of the Rag GTPase Signaling Network. Biomolecules (2017) 0.75
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development (1993) 58.26
TOR signaling in growth and metabolism. Cell (2006) 35.29
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med (2007) 24.19
Defining the role of mTOR in cancer. Cancer Cell (2007) 21.63
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science (2008) 14.08
Cancer cell metabolism: Warburg and beyond. Cell (2008) 11.80
Principles of cancer therapy: oncogene and non-oncogene addiction. Cell (2009) 10.96
PI3K pathway alterations in cancer: variations on a theme. Oncogene (2008) 9.94
Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol (2008) 8.92
Bidirectional transport of amino acids regulates mTOR and autophagy. Cell (2009) 7.88
Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell (2005) 7.87
Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc Natl Acad Sci U S A (2005) 7.21
Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell (1993) 6.44
hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase. J Biol Chem (2005) 5.22
Tumours with PI3K activation are resistant to dietary restriction. Nature (2009) 3.60
A conserved GTPase-containing complex is required for intracellular sorting of the general amino-acid permease in yeast. Nat Cell Biol (2006) 3.57
Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines. Mol Cancer Res (2007) 3.21
Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol (2005) 3.12
Amino acid regulation of TOR complex 1. Am J Physiol Endocrinol Metab (2008) 3.03
Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling. Genes Dev (2002) 2.87
Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability. Biochem J (2003) 2.84
Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther (2008) 2.79
A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling. Biochem J (2007) 2.69
A new mutational AKTivation in the PI3K pathway. Cancer Cell (2007) 2.62
Localization of Rheb to the endomembrane is critical for its signaling function. Biochem Biophys Res Commun (2006) 2.45
dS6K-regulated cell growth is dPKB/dPI(3)K-independent, but requires dPDK1. Nat Cell Biol (2002) 2.31
Regulation of tissue growth through nutrient sensing. Annu Rev Genet (2009) 2.18
The gene search system. A method for efficient detection and rapid molecular identification of genes in Drosophila melanogaster. Genetics (1999) 2.09
Intracellular sensing of amino acids in Xenopus laevis oocytes stimulates p70 S6 kinase in a target of rapamycin-dependent manner. J Biol Chem (2002) 2.09
Nutrient-dependent regulation of autophagy through the target of rapamycin pathway. Biochem Soc Trans (2009) 1.91
Identification and characterization of a lysosomal transporter for small neutral amino acids. Proc Natl Acad Sci U S A (2001) 1.88
Tumours and tremors: how PTEN regulation underlies both. Br J Cancer (2006) 1.70
Surface antigen CD98(4F2): not a single membrane protein, but a family of proteins with multiple functions. J Membr Biol (2000) 1.69
Amino acid transceptors: gate keepers of nutrient exchange and regulators of nutrient signaling. Am J Physiol Endocrinol Metab (2009) 1.68
Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metab Pharmacokinet (2005) 1.57
PAT-related amino acid transporters regulate growth via a novel mechanism that does not require bulk transport of amino acids. Development (2005) 1.57
The functions of insulin signaling: size isn't everything, even in Drosophila. Differentiation (2003) 1.55
The SLC36 family: proton-coupled transporters for the absorption of selected amino acids from extracellular and intracellular proteolysis. Pflugers Arch (2003) 1.47
Endocrine regulation of aging and reproduction in Drosophila. Mol Cell Endocrinol (2008) 1.44
Cancer, type 2 diabetes, and ageing: news from flies and worms. Swiss Med Wkly (2004) 1.34
Everolimus. Nat Rev Drug Discov (2009) 1.29
Structure, function and immunolocalization of a proton-coupled amino acid transporter (hPAT1) in the human intestinal cell line Caco-2. J Physiol (2003) 1.23
Functional characterization of two novel mammalian electrogenic proton-dependent amino acid cotransporters. J Biol Chem (2002) 1.22
The H+-coupled electrogenic lysosomal amino acid transporter LYAAT1 localizes to the axon and plasma membrane of hippocampal neurons. J Neurosci (2003) 1.07
Amino acid sensing and mTOR regulation: inside or out? Biochem Soc Trans (2009) 1.03
An amino acid shuffle activates mTORC1. Cell (2009) 1.01
The proton/amino acid cotransporter PAT2 is expressed in neurons with a different subcellular localization than its paralog PAT1. J Biol Chem (2003) 0.96
Organization and expression of the SLC36 cluster of amino acid transporter genes. Mamm Genome (2004) 0.94
Amino acid transporters and nutrient-sensing mechanisms: new targets for treating insulin-linked disorders? Biochem Soc Trans (2007) 0.93
Evidence that the rabbit proton-peptide co-transporter PepT1 is a multimer when expressed in Xenopus laevis oocytes. Pflugers Arch (2006) 0.86
Signal transduction: Linking nutrients to growth. Nature (2008) 0.84
Effect of general practitioners' advice against smoking. Br Med J (1979) 24.07
THE NATURE OF THE PERIPHERAL RESISTANCE IN ARTERIAL HYPERTENSION WITH SPECIAL REFERENCE TO THE VASOMOTOR SYSTEM. J Clin Invest (1936) 18.94
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol (2000) 16.83
Intercapillary Lesions in the Glomeruli of the Kidney. Am J Pathol (1936) 12.50
Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med (1999) 11.27
A plethysmographic method for measuring systolic blood pressure in the intact rat. J Physiol (1938) 7.20
Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet (2001) 6.92
Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol (1991) 6.19
P-element-mediated enhancer detection: a versatile method to study development in Drosophila. Genes Dev (1989) 5.76
Benign and Malignant Hypertension and Nephrosclerosis: A Clinical and Pathological Study. Am J Pathol (1936) 4.43
Genetic evidence for the spread of agriculture in Europe by demic diffusion. Nature (1991) 4.34
A cytogenetic study of 1000 spontaneous abortions. Ann Hum Genet (1980) 3.82
Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature (1984) 3.64
Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci U S A (1997) 3.61
Inflammatory Lesions in the Glomeruli in Pyelonephritis in Relation to Hypertension and Renal Insufficiency. Am J Pathol (1936) 3.52
New world views: preparing physicians in training for global health work. Fam Med (2000) 3.23
A JNK signal transduction pathway that mediates morphogenesis and an immune response in Drosophila. Genes Dev (1996) 3.21
Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene. Cell (1988) 2.91
Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway. Genes Dev (1999) 2.87
Plasma nicotine levels after smoking cigarettes with high, medium, and low nicotine yields. Br Med J (1975) 2.80
Structure of the CAP-DNA complex at 2.5 angstroms resolution: a complete picture of the protein-DNA interface. J Mol Biol (1996) 2.80
Comparison of effect on tobacco consumption and carbon monoxide absorption of changing to high and low nicotine cigarettes. Br Med J (1973) 2.65
RNA secondary structure prediction based on free energy and phylogenetic analysis. J Mol Biol (1999) 2.65
Effect of nicotine chewing gum on smoking behaviour and as an aid to cigarette withdrawal. Br Med J (1976) 2.41
A computer-derived protocol to aid in the diagnosis of emergency room patients with acute chest pain. N Engl J Med (1982) 2.28
Mobile coronary care and community mortality from myocardial infarction. Lancet (1985) 2.27
Stimulation and suppression of PCR-mediated recombination. Nucleic Acids Res (1998) 2.17
Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther (1995) 2.11
A microtest for the quantitation of rabies virus neutralizing antibodies. J Biol Stand (1979) 2.10
The treatment and prevention of obesity: a systematic review of the literature. Int J Obes Relat Metab Disord (1997) 2.10
Improving the detection rate of early gastric cancer requires more than open access gastroscopy: a five year study. Gut (1997) 2.09
On the scale of global demographic convergence, 1950-2000. Popul Dev Rev (2001) 2.07
Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.06
Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem (1994) 2.04
HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells. Oncogene (2007) 2.00
Antibodies to proteus in rheumatoid arthritis. Lancet (1985) 1.96
Therapeutic Trial of Methionine in Infective Hepatitis. Br Med J (1945) 1.95
Acute chest pain in the emergency room. Identification and examination of low-risk patients. Arch Intern Med (1985) 1.86
The rat lipolytic beta-adrenoceptor: studies using novel beta-adrenoceptor agonists. Eur J Pharmacol (1984) 1.85
UV-Stimulated K Efflux from Rose Cells: Counterion and Inhibitor Studies. Plant Physiol (1982) 1.85
Comparison of increases in carboxyhaemoglobin after smoking "extra-mild" and "non-mild" cigarettes. Lancet (1973) 1.84
Perturbation of Chara Plasmalemma Transport Function by 2[4(2',4'-Dichlorophenoxy)phenoxy]propionic Acid. Plant Physiol (1984) 1.83
Variability of the lytic susceptibility of Neisseria gonorrhoeae to human sera. J Immunol (1977) 1.81
Idiopathic granulomatous mastitis. A report of three cases and review of the literature. Arch Pathol Lab Med (1994) 1.79
Characterization of the humoral immune response to Klebsiella species in inflammatory bowel disease and ankylosing spondylitis. Br J Rheumatol (1998) 1.69
GSK3: a SHAGGY frog story. Trends Cell Biol (1996) 1.65
An analysis using DNA microarray of the time course of gene expression during syncytialization of a human placental cell line (BeWo). Placenta (2004) 1.62
Increased antibiotic resistance of Neisseria gonorrhoeae in Korea. Antimicrob Agents Chemother (1976) 1.58
Evaluation of chromogenic meticillin-resistant Staphylococcus aureus media: sensitivity versus turnaround time. J Hosp Infect (2012) 1.58
Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. Hum Mol Genet (1997) 1.55
Appendicitis in pregnancy: an ongoing diagnostic dilemma. Colorectal Dis (2008) 1.54
Association of dehydroepiandrosterone sulfate, body composition, and physical fitness in independent community-dwelling older men and women. J Am Geriatr Soc (1998) 1.53
Co-induction and laryngeal mask insertion. A comparison of thiopentone versus propofol. Anaesthesia (1997) 1.52
Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat. Br J Pharmacol (1989) 1.52
2.8 A crystal structure of the malachite green aptamer. J Mol Biol (2000) 1.49
Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet (1990) 1.49
The structural basis for molecular recognition by the vitamin B 12 RNA aptamer. Nat Struct Biol (2000) 1.48
Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer (2006) 1.48
Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone. Mol Endocrinol (1994) 1.46
Increased cationic amino acid flux through a newly expressed transporter in cells overproducing nitric oxide from patients with septic shock. Clin Sci (Lond) (2002) 1.45
Targeting motifs and functional parameters governing the assembly of connexins into gap junctions. Biochem J (2000) 1.45
Defibrillators in general practice. Br Med J (Clin Res Ed) (1984) 1.45
Extended forensic evaluation when sexual abuse is suspected: a multisite field study. Child Maltreat (2001) 1.43
Is rheumatoid arthritis a form of reactive arthritis? J Rheumatol (2000) 1.42
Trichomycosis axillaris: a different view. J Am Acad Dermatol (1989) 1.42
An advance notification letter increases participation in colorectal cancer screening. J Med Screen (2007) 1.42
Prospective comparison of clinical and echocardiographic diagnosis of rheumatic carditis: long term follow up of patients with subclinical disease. Heart (2001) 1.42
Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation, and fear. J Neurosci (1996) 1.38
Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-beta 1. Am J Pathol (1995) 1.37
1995 Standards for Acute Care Organizations not responsive to customer voices. Leadersh Health Serv (1995) 1.37
Mutations of the mitochondrial ND1 gene as a cause of MELAS. J Med Genet (2004) 1.35
Acute superior mesenteric ischaemia. Br J Surg (1987) 1.35
P-element-mediated enhancer detection applied to the study of oogenesis in Drosophila. Development (1989) 1.34
Laser-mediated, site-specific inactivation of RNA transcripts. Proc Natl Acad Sci U S A (1999) 1.34
An interstitial deletion of chromosome 9 in a girl with multiple congenital anomalies. J Med Genet (1977) 1.30
St-segment displacement and early hospital discharge in acute myocardial infarction. Lancet (1973) 1.28
Hair follicle stem cells: their location, role in hair cycle, and involvement in skin tumor formation. J Invest Dermatol (1993) 1.26
Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome. Lancet (1981) 1.24
Rheumatoid arthritis and Proteus: a possible aetiological association. Rheumatol Int (1989) 1.24
Low acute insulin secretory responses in adult offspring of people with early onset type 2 diabetes. Diabetes (2001) 1.23
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy. Diabetes Obes Metab (2009) 1.22
Identification of target genes of the homeotic gene Antennapedia by enhancer detection. Genes Dev (1991) 1.22
Klebsiella antibodies in ankylosing spondylitis and Proteus antibodies in rheumatoid arthritis. Br J Rheumatol (1988) 1.22
A comparative interaction of epinephrine with enflurane, isoflurane, and halothane in man. Anesth Analg (1976) 1.21
Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer. Br J Cancer (2007) 1.21
Anti-müllerian hormone: the Jost factor. Recent Prog Horm Res (1993) 1.21
Evidence for evolutionarily conserved secondary structure in the H19 tumor suppressor RNA. Nucleic Acids Res (2000) 1.20
Impaired antioxidant defence and accumulation of oxidative stress in caspase-2-deficient mice. Cell Death Differ (2012) 1.19
The 1.3 A crystal structure of a biotin-binding pseudoknot and the basis for RNA molecular recognition. J Mol Biol (2000) 1.17
Isolation and characterization of fluorophore-binding RNA aptamers. Fold Des (1998) 1.16
Beta-adrenoceptor subtypes in human, rat, guinea pig, and rabbit atria. J Cardiovasc Pharmacol (1985) 1.15
A multi-centre study of the community needs of people with spinal cord injuries: the first 18 months. Spinal Cord (2009) 1.15
Mouse skin is particularly susceptible to tumor initiation during early anagen of the hair cycle: possible involvement of hair follicle stem cells. J Invest Dermatol (1993) 1.14
Cardiovascular safety of the dipetidyl peptidase-4 inhibitor alogliptin in type 2 diabetes mellitus. Diabetes Obes Metab (2013) 1.13
Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta. J Reprod Immunol (2004) 1.13
The emerging role of mTORC1 signaling in placental nutrient-sensing. Placenta (2012) 1.12
Competitive displacement of DNA during surface hybridization. Biophys J (2006) 1.12
Sequence similarity between HLA-DR1 and DR4 subtypes associated with rheumatoid arthritis and proteus/serratia membrane haemolysins. Ann Rheum Dis (1992) 1.11
The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer. Br J Cancer (2008) 1.10
XRCC2 is a nuclear RAD51-like protein required for damage-dependent RAD51 focus formation without the need for ATP binding. J Biol Chem (2001) 1.10